• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用噬菌体和益生菌治疗体外肠出血性大肠杆菌感染。

Treatment of in vitro enterohemorrhagic Escherichia coli infection using phage and probiotics.

作者信息

Dini C, Bolla P A, de Urraza P J

机构信息

Center for Research and Development in Food Cryotechnology (CIDCA - CONICET-UNLP) CCT La Plata, La Plata, Argentina.

Cátedra de Microbiología, Facultad de Ciencias Exactas, UNLP, La Plata, Argentina.

出版信息

J Appl Microbiol. 2016 Jul;121(1):78-88. doi: 10.1111/jam.13124. Epub 2016 May 30.

DOI:10.1111/jam.13124
PMID:26969848
Abstract

AIMS

To assay the combination of phage and probiotics against EHEC in vitro on infected Hep-2 cells.

METHODS AND RESULTS

Phage and probiotics treatments on EHEC O157:H7-infected Hep-2 cells were assayed individually or combined. The effect of freeze-drying on phage and probiotic antimicrobial activity was also studied. While treatment with phage alone increased cell detachment caused by EHEC infection, the treatments with MM alone or in combination with phage proved to effectively diminish cell damage caused by EHEC infection. Combined treatment showed a decrease in apoptotic cell count of 57·3% and a reduction in EHEC adhesion to cell monolayer of 1·2 log CFU. The simultaneous use of phage and probiotics showed no antagonistic effect, and freeze-drying did not affect their antipathogenic activity.

CONCLUSIONS

The combination of phage and probiotics has great potential for reducing the number of pathogens adhered to epithelial cells during EHEC O157:H7 infection and attenuating the cytotoxic effect derived from it. Further in vivo assays are needed for assessing the actual effectiveness of the treatment.

SIGNIFICANCE AND IMPACT OF THE STUDY

This study presents a freeze-dried formulation of phage and probiotics capable of controlling EHEC infections and reducing epithelial cell damage in vitro.

摘要

目的

在体外感染的Hep - 2细胞上检测噬菌体与益生菌联合对抗肠出血性大肠杆菌(EHEC)的效果。

方法与结果

分别或联合检测噬菌体和益生菌对EHEC O157:H7感染的Hep - 2细胞的处理效果。还研究了冷冻干燥对噬菌体和益生菌抗菌活性的影响。单独使用噬菌体处理会增加由EHEC感染引起的细胞脱落,而单独使用MM或与噬菌体联合使用的处理方法被证明能有效减轻EHEC感染引起的细胞损伤。联合处理使凋亡细胞计数减少了57.3%,EHEC对细胞单层的黏附减少了1.2 log CFU。同时使用噬菌体和益生菌未显示出拮抗作用,且冷冻干燥不影响它们的抗病原活性。

结论

噬菌体与益生菌联合在减少EHEC O157:H7感染期间黏附于上皮细胞的病原体数量以及减轻由此产生的细胞毒性作用方面具有巨大潜力。需要进一步进行体内试验以评估该治疗方法的实际有效性。

研究的意义和影响

本研究提出了一种能够在体外控制EHEC感染并减少上皮细胞损伤的噬菌体和益生菌冷冻干燥制剂。

相似文献

1
Treatment of in vitro enterohemorrhagic Escherichia coli infection using phage and probiotics.使用噬菌体和益生菌治疗体外肠出血性大肠杆菌感染。
J Appl Microbiol. 2016 Jul;121(1):78-88. doi: 10.1111/jam.13124. Epub 2016 May 30.
2
Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.益生菌大肠杆菌 Nissle 1917 对 O104:H4 和 O157:H7 血清型肠出血性大肠杆菌菌株的拮抗作用。
Int J Med Microbiol. 2013 Jan;303(1):1-8. doi: 10.1016/j.ijmm.2012.11.006. Epub 2013 Jan 10.
3
The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.丁酸梭菌益生菌治疗对小鼠肠出血性大肠杆菌O157:H7感染的影响。
FEMS Immunol Med Microbiol. 2004 Jul 1;41(3):219-26. doi: 10.1016/j.femsim.2004.03.010.
4
Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1.益生菌可预防肠出血性大肠杆菌O157:H7介导的对干扰素-γ诱导的信号转导和转录激活因子1(STAT-1)酪氨酸磷酸化的抑制作用。
Microbiology (Reading). 2009 Feb;155(Pt 2):531-540. doi: 10.1099/mic.0.021931-0.
5
Efficacy of a lytic bacteriophage vB_EcoM_SQ17 against Enterohemorrhagic Escherichia coli O157:H7 and Enterotoxigenic E. coli biofilms on cucumber.裂解噬菌体 vB_EcoM_SQ17 对黄瓜上产志贺样毒素且具侵袭性大肠杆菌 O157:H7 和肠致病性大肠杆菌生物膜的杀菌效果。
Microb Pathog. 2024 Sep;194:106832. doi: 10.1016/j.micpath.2024.106832. Epub 2024 Jul 31.
6
Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota.解淀粉芽胞杆菌 TL106 通过改善免疫应答、肠道屏障功能和肠道微生物群来保护小鼠免受肠出血性大肠杆菌 O157:H7 诱导的肠道疾病。
J Appl Microbiol. 2021 Jul;131(1):470-484. doi: 10.1111/jam.14952. Epub 2020 Dec 18.
7
Encoded protein from ycbR gene of enterohemorrhagic Escherichia coli O157:H7 associated with adherence to HEp-2 cells.肠出血性大肠杆菌O157:H7的ycbR基因编码的蛋白质与对HEp-2细胞的黏附有关。
Microbiol Res. 2014 Nov;169(11):855-61. doi: 10.1016/j.micres.2014.03.001. Epub 2014 Mar 12.
8
Effects of Lactobacillus kefiranofaciens M1 isolated from kefir grains on enterohemorrhagic Escherichia coli infection using mouse and intestinal cell models.从开菲尔粒中分离出的开菲尔乳杆菌M1对使用小鼠和肠道细胞模型的肠出血性大肠杆菌感染的影响。
J Dairy Sci. 2013;96(12):7467-77. doi: 10.3168/jds.2013-7015. Epub 2013 Oct 17.
9
Effect of molecules secreted by Lactobacillus acidophilus strain La-5 on Escherichia coli O157:H7 colonization.嗜酸乳杆菌La-5菌株分泌的分子对大肠杆菌O157:H7定植的影响。
Appl Environ Microbiol. 2009 Feb;75(4):1165-72. doi: 10.1128/AEM.01651-08. Epub 2008 Dec 16.
10
Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer's patches.肠出血性大肠杆菌感染对人类肠道微生物群具有供体依赖性影响,并且在与派尔集合淋巴结相互作用期间可能受到益生菌酵母的拮抗。
Appl Microbiol Biotechnol. 2015 Nov;99(21):9097-110. doi: 10.1007/s00253-015-6704-0. Epub 2015 Jun 18.

引用本文的文献

1
Re-Emergence of Bacteriophages and Their Products as Antibacterial Agents: An Overview.噬菌体及其产物作为抗菌剂的再度兴起:概述
Int J Mol Sci. 2025 Feb 19;26(4):1755. doi: 10.3390/ijms26041755.
2
What, how, and why? - anti-EHEC phages and their application potential in medicine and food industry.是什么、如何以及为何?——抗肠出血性大肠杆菌噬菌体及其在医学和食品工业中的应用潜力
J Appl Genet. 2025 Feb;66(1):219-240. doi: 10.1007/s13353-024-00918-4. Epub 2024 Nov 11.
3
The Potential of Bacteriophage-Antibiotic Combination Therapy in Treating Infections with Multidrug-Resistant Bacteria.
噬菌体-抗生素联合疗法治疗多重耐药菌感染的潜力
Antibiotics (Basel). 2023 Aug 17;12(8):1329. doi: 10.3390/antibiotics12081329.
4
Bacteriophages targeting protective commensals impair resistance against Salmonella Typhimurium infection in gnotobiotic mice.靶向保护性共生菌的噬菌体可损害无菌小鼠抵抗鼠伤寒沙门氏菌感染的能力。
PLoS Pathog. 2023 Aug 21;19(8):e1011600. doi: 10.1371/journal.ppat.1011600. eCollection 2023 Aug.
5
Synergistic Effects of Bacteriophage vB_Eco4-M7 and Selected Antibiotics on the Biofilm Formed by Shiga Toxin-Producing .噬菌体vB_Eco4-M7与选定抗生素对产志贺毒素菌形成的生物膜的协同作用
Antibiotics (Basel). 2022 May 25;11(6):712. doi: 10.3390/antibiotics11060712.
6
AB Enterotoxin-Mediated Pathogenesis: Perspectives Gleaned from Shiga Toxins.AB 肠毒素介导的发病机制:从志贺毒素中获得的观点。
Toxins (Basel). 2022 Jan 16;14(1):62. doi: 10.3390/toxins14010062.
7
Strain specific motility patterns and surface adhesion of virulent and probiotic Escherichia coli.毒力型和益生菌型大肠杆菌的菌株特异性运动模式和表面黏附特性。
Sci Rep. 2022 Jan 12;12(1):614. doi: 10.1038/s41598-021-04592-y.
8
Utilizing Probiotics for the Prevention and Treatment of Gastrointestinal Diseases.利用益生菌预防和治疗胃肠道疾病。
Front Microbiol. 2021 Aug 9;12:689958. doi: 10.3389/fmicb.2021.689958. eCollection 2021.
9
Treatment Strategies for Infections With Shiga Toxin-Producing .产志贺毒素大肠埃希氏菌感染的治疗策略。
Front Cell Infect Microbiol. 2020 May 6;10:169. doi: 10.3389/fcimb.2020.00169. eCollection 2020.
10
Antimicrobial Activity of a Phage Mixture and a Lactic Acid Bacterium against from Bovine Mastitis.噬菌体混合物和乳酸菌对牛乳腺炎病原体的抗菌活性
Vet Sci. 2020 Mar 6;7(1):31. doi: 10.3390/vetsci7010031.